Antithrombotic Treatments in Patients With SARS-CoV-2 Infection: From Current Evidence to Reasonable Recommendations - A Position Paper From the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology

被引：5
|
作者：
Patti, Giuseppe [1 ]
Lio, Veronica [1 ]
Cavallari, Ilaria [2 ]
Gragnano, Felice [3 ]
Riva, Letizia [4 ]
Calabro, Paolo [3 ]
Di Pasquale, Giuseppe [4 ]
Pengo, Vittorio [5 ,6 ]
Rubboli, Andrea [7 ]
机构：
[1] Univ Piemonte Orientale, Osped Maggiore Carita, Cattedra Cardiol, Novara, Italy
[2] Univ Campus Biomed, Rome, Italy
[3] Univ Campania Luigi Vanvitelli, Cattedra Cardiol, UOC Cardiol, AORN St Anna & San Sebastiano,UTIC, Caserta, Italy
[4] Osped Maggiore Bologna, UOC Cardiol, Bologna, Italy
[5] Univ Padua, Lab Ric Trombosi, Campus Biomed Pietro Abano, Padua, Italy
[6] Fdn Arianna Anticoagulaz, Bologna, Italy
[7] Osped S Maria Croci, UO Cardiol, AUSL Romagna, Dipartimento Cardiovasc, Ravenna, Italy
来源：
GIORNALE ITALIANO DI CARDIOLOGIA | 2020年 / 21卷 / 07期
关键词：
Coronavirus; Anticoagulant treatment; Antiplatelet therapy; Thrombosis; VENOUS THROMBOEMBOLISM PROPHYLAXIS; EAST RESPIRATORY SYNDROME; ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; ESC GUIDELINES; MANAGEMENT; WARFARIN; MODEL; LOPINAVIR/RITONAVIR; COAGULOPATHY;
D O I：
10.1714/3386.33634
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Given the high prevalence of preexisting cardiovascular diseases and the increased incidence of adverse cardiovascular events in patients hospitalized for SARS-CoV-2 infection, the identification of optimal antithrombotic approaches in terms of risk/benefit ratio and outcome improvement appears crucial in this setting. In the present position paper we collected current evidence from the literature to provide practical recommendations on the management of antithrombotic therapies (antiplatelet and anticoagulant) in various clinical contexts prevalent during the SARS-CoV-2 outbreak: in-home management of oral anticoagulant therapy; interactions between drugs used in the SARS-CoV-2 infection and antithrombotic agents; in-hospital management of antithrombotic therapies; diagnosis, risk stratification and treatment of in-hospital thrombotic complications.
引用
收藏
页码：489 / 501
页数：13
相关论文
共 34 条
  • [21] Considerations for the management of home parenteral nutrition during the SARS-CoV-2 pandemic: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN
    Lal, Simon
    Van Gossum, Andre
    Joly, Francisca
    Bozzetti, Federico
    Cuerda, Cristina
    Lamprecht, Georg
    Mundi, Manpreet S.
    Staun, Michael
    Szczepanek, Kinga
    Wanten, Geert
    Wheatley, Carolyn
    Pironi, Loris
    CLINICAL NUTRITION, 2020, 39 (07) : 1988 - 1991
  • [22] LATE EVIDENCE OF SARS-COV-2 INFECTION IN A PATIENT WITH ACUTE KIDNEY INJURY (AKI) AND MASSIVE DEEP VEIN THROMBOSIS (DVT) STARTING FROM A HEMODIALYSIS CENTRAL VENOUS CATHETER (CVC)
    Di Vico, Deborah
    Cersosimo, Katia
    Fofi, Claudia
    Moioli, Alessandra
    Tipaldi, Marcello Andrea
    Grossi, Stefano
    Mene, Paolo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [23] Contemporary rationale for non-invasive imaging of adverse coronary plaque features to identify the vulnerable patient: a Position Paper from the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology and the European Association of Cardiovascular Imaging
    Dweck, Marc R.
    Maurovich-Horvat, Pal
    Leiner, Tim
    Cosyns, Bernard
    Fayad, Zahi A.
    Gijsen, Frank J. H.
    Van der Heiden, Kim
    Kooi, M. Eline
    Maehara, Akiko
    Muller, James E.
    Newby, David E.
    Narula, Jagat
    Pontone, Gianluca
    Regar, Evelyn
    Serruys, Patrick W.
    van der Steen, Antonius F. W.
    Stone, Peter H.
    Waltenberger, Johannes L.
    Yuan, Chun
    Evans, Paul C.
    Lutgens, Esther
    Wentzel, Jolanda J.
    Back, Magnus
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2020, 21 (11) : 1177 - 1183
  • [24] Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
    Pinato, David J.
    Tabernero, Josep
    Bower, Mark
    Scotti, Lorenza
    Patel, Meera
    Colomba, Emeline
    Dolly, Saoirse
    Loizidou, Angela
    Chester, John
    Mukherjee, Uma
    Zambelli, Alberto
    Dalla Pria, Alessia
    Aguilar-Company, Juan
    Ottaviani, Diego
    Chowdhury, Amani
    Merry, Eve
    Salazar, Ramon
    Bertuzzi, Alexia
    Brunet, Joan
    Lambertini, Matteo
    Tagliamento, Marco
    Pous, Anna
    Sita-Lumsden, Ailsa
    Srikandarajah, Krishnie
    Colomba, Johann
    Pommeret, Fanny
    Segui, Elia
    Generali, Daniele
    Grisanti, Salvatore
    Pedrazzoli, Paolo
    Rizzo, Gianpiero
    Libertini, Michela
    Moss, Charlotte
    Evans, Joanne S.
    Russell, Beth
    Harbeck, Nadia
    Vincenzi, Bruno
    Biello, Federica
    Bertulli, Rossella
    Linan, Raquel
    Rossi, Sabrina
    Carmona-Garcia, Maria Carmen
    Tondini, Carlo
    Fox, Laura
    Baggi, Alice
    Fotia, Vittoria
    Parisi, Alessandro
    Porzio, Giampero
    Saponara, Maristella
    Cruz, Claudia Andrea
    LANCET ONCOLOGY, 2021, 22 (12): : 1669 - 1680
  • [25] COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety
    Nicoletta Luxi
    Alexia Giovanazzi
    Annalisa Capuano
    Salvatore Crisafulli
    Paola Maria Cutroneo
    Maria Pia Fantini
    Carmen Ferrajolo
    Ugo Moretti
    Elisabetta Poluzzi
    Emanuel Raschi
    Claudia Ravaldi
    Chiara Reno
    Marco Tuccori
    Alfredo Vannacci
    Giovanna Zanoni
    Gianluca Trifirò
    Drug Safety, 2021, 44 : 1247 - 1269
  • [26] COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety
    Luxi, Nicoletta
    Giovanazzi, Alexia
    Capuano, Annalisa
    Crisafulli, Salvatore
    Cutroneo, Paola Maria
    Fantini, Maria Pia
    Ferrajolo, Carmen
    Moretti, Ugo
    Poluzzi, Elisabetta
    Raschi, Emanuel
    Ravaldi, Claudia
    Reno, Chiara
    Tuccori, Marco
    Vannacci, Alfredo
    Zanoni, Giovanna
    Trifiro, Gianluca
    DRUG SAFETY, 2021, 44 (12) : 1247 - 1269
  • [27] No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020
    Panatto, Donatella
    Orsi, Andrea
    Pennati, Beatrice Marina
    Lai, Piero Luigi
    Mosca, Stefano
    Bruzzone, Bianca
    Caligiuri, Patrizia
    Napoli, Christian
    Bertamino, Enrico
    Orsi, Giovanni Battista
    Manini, Ilaria
    Loconsole, Daniela
    Centrone, Francesca
    Pandolfi, Elisabetta
    Ciofi Degli Atti, Marta Luisa
    Concato, Carlo
    Linardos, Giulia
    Onetti Muda, Andrea
    Raponi, Massimiliano
    Piccioni, Livia
    Rizzo, Caterina
    Chironna, Maria
    Icardi, Giancarlo
    PLOS ONE, 2021, 16 (12):
  • [28] Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)
    Daniele Zama
    Francesco Baccelli
    Antonella Colombini
    Amalia Contino
    Elisabetta Calore
    Maria Grazia Petris
    Linda Meneghello
    Federico Mercolini
    Andrea Lo Vecchio
    Shana Montalto
    Cristina Meazza
    Angelica Barone
    Francesca Compagno
    Paola Muggeo
    Elena Soncini
    Letizia Brescia
    Eugenia Giraldi
    Nagua Giurici
    Rosa Maria Mura
    Monica Cellini
    Katia Perruccio
    Valeria Petroni
    Milena La Spina
    Ottavio Ziino
    Roberta Burnelli
    Raffaella De Santis
    Maurizio Mascarin
    Valentina Barretta
    Gloria Tridello
    Simone Cesaro
    Annals of Hematology, 2022, 101 : 1843 - 1851
  • [29] Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)
    Zama, Daniele
    Baccelli, Francesco
    Colombini, Antonella
    Contino, Amalia
    Calore, Elisabetta
    Petris, Maria Grazia
    Meneghello, Linda
    Mercolini, Federico
    Lo Vecchio, Andrea
    Montalto, Shana
    Meazza, Cristina
    Barone, Angelica
    Compagno, Francesca
    Muggeo, Paola
    Soncini, Elena
    Brescia, Letizia
    Giraldi, Eugenia
    Giurici, Nagua
    Mura, Rosa Maria
    Cellini, Monica
    Perruccio, Katia
    Petroni, Valeria
    La Spina, Milena
    Ziino, Ottavio
    Burnelli, Roberta
    De Santis, Raffaella
    Mascarin, Maurizio
    Barretta, Valentina
    Tridello, Gloria
    Cesaro, Simone
    ANNALS OF HEMATOLOGY, 2022, 101 (08) : 1843 - 1851
  • [30] Early 3-day course of remdesivir to prevent progression to severe Covid-19 in high-risk patients with hospital-acquired SARS-CoV-2 infection: preliminary results from two Italian outbreaks
    Meini, Simone
    Bracalente, Irene
    Bontempo, Giulia
    Longo, Benedetta
    De Martino, Maria
    Tascini, Carlo
    NEW MICROBIOLOGICA, 2022, 45 (04): : 304 - 307
1234